York Hospital
- Type
- Teaching hospital
- Where
- YORK, PA
- Medicare CCN
- 390046
- Received
- $96,484 in 58 records, 2021 ($20,160 general, $76,323 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: York Hospital Fuzzy (name and state)
- Nonprofit: YORK HOSPITAL Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2021 | General payment | 20 | $20,160 |
| 2021 | Research payment | 38 | $76,323 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Edwards Lifesciences Corporation | 16 | $51,516 | 2021 |
| GW Research Limited | 1 | $11,656 | 2021 |
| Johnson & Johnson Health Care Systems Inc. | 8 | $8,111 | 2021 |
| Incyte Corporation | 1 | $5,742 | 2021 |
| Shockwave Medical, Inc | 2 | $5,589 | 2021 |
| Boehringer Ingelheim International GmbH | 12 | $5,060 | 2021 |
| Zimmer Biomet Holdings, Inc. | 1 | $2,500 | 2021 |
| Medical Device Business Services, Inc. | 1 | $1,250 | 2021 |
| Eli Lilly and Company | 2 | $1,145 | 2021 |
| LEICA MICROSYSTEMS INC. | 3 | $1,092 | 2021 |
| Linvatec Corporation | 2 | $1,045 | 2021 |
| Becton, Dickinson and Company | 1 | $955 | 2021 |
| Aesculap, Inc. | 2 | $484 | 2021 |
| Boston Scientific Corporation | 5 | $247 | 2021 |
| Siemens Medical Solutions USA, Inc. | 1 | $87 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 38 | $76,323 |
| Debt forgiveness | 11 | $8,683 |
| Long term medical supply or device loan | 4 | $6,635 |
| Grant | 2 | $3,750 |
| Education | 3 | $1,092 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | Shockwave Medical, Inc | $2,794 | Long term medical supply or device loan | In-kind items and services | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Lithoplasty | 2021 | |
| 2021-12-31 | Shockwave Medical, Inc | $2,794 | Long term medical supply or device loan | In-kind items and services | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Device, Lithoplasty | 2021 | |
| 2021-12-31 | Linvatec Corporation | $135 | Long term medical supply or device loan | In-kind items and services | HALL POWER Device, ORTHOPEDIC SURGERY | 2021 | |
| 2021-12-31 | Siemens Medical Solutions USA, Inc. | $87 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-12-13 | Becton, Dickinson and Company | $955 | Research payment | Cash or cash equivalent | BD Veritor InfoScan Module Device, Diagnostic Systems | Veritor Antigen Assay | 2021 |
| 2021-12-06 | Edwards Lifesciences Corporation | $1,471 | Research payment | Cash or cash equivalent | Early-TAVR Trial #2016-07 | 2021 | |
| 2021-12-06 | Edwards Lifesciences Corporation | $750 | Research payment | Cash or cash equivalent | Early-TAVR Trial #2016-07 | 2021 | |
| 2021-10-28 | Medical Device Business Services, Inc. | $1,250 | Grant | Cash or cash equivalent | 2021 | ||
| 2021-10-18 | Edwards Lifesciences Corporation | $6,273 | Research payment | Cash or cash equivalent | Partner3 2015-08 | 2021 | |
| 2021-10-12 | Edwards Lifesciences Corporation | $144 | Research payment | Cash or cash equivalent | PARTNER II (2010-12) | 2021 | |
| 2021-10-06 | Linvatec Corporation | $910 | Long term medical supply or device loan | In-kind items and services | LINVATEC ARTHROSCOPY Device, ORTHOPEDIC SURGERY | 2021 | |
| 2021-10-01 | Boehringer Ingelheim International GmbH | $1,672 | Research payment | Cash or cash equivalent | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-09-30 | Edwards Lifesciences Corporation | $1,250 | Research payment | Cash or cash equivalent | EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE (THV) Device, Transcatheter Heart Valves | PARTNER II (2010-12) | 2021 |
| 2021-09-23 | Edwards Lifesciences Corporation | $2,289 | Research payment | Cash or cash equivalent | Early-TAVR Trial #2016-07 | 2021 | |
| 2021-09-17 | Boehringer Ingelheim International GmbH | $956 | Research payment | Cash or cash equivalent | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-09-17 | Boehringer Ingelheim International GmbH | $462 | Research payment | Cash or cash equivalent | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-09-09 | LEICA MICROSYSTEMS INC. | $554 | Education | In-kind items and services | SENTIMAG Device, Devices | 2021 | |
| 2021-09-09 | LEICA MICROSYSTEMS INC. | $269 | Education | In-kind items and services | SENTIMAG Device, Devices | 2021 | |
| 2021-09-09 | LEICA MICROSYSTEMS INC. | $269 | Education | In-kind items and services | SENTIMAG Device, Devices | 2021 | |
| 2021-08-19 | Edwards Lifesciences Corporation | $1,990 | Research payment | Cash or cash equivalent | PARTNER II (2010-12) | 2021 | |
| 2021-08-12 | Edwards Lifesciences Corporation | $3,115 | Research payment | Cash or cash equivalent | Partner3 2015-08 | 2021 | |
| 2021-08-03 | Aesculap, Inc. | $249 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-08-03 | Aesculap, Inc. | $235 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-07-27 | Eli Lilly and Company | $759 | Research payment | In-kind items and services | EMONARCHER: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF ABEMACICLIB PLUS STANDARD ADJUVANT ENDOCRINE | 2021 | |
| 2021-07-21 | Zimmer Biomet Holdings, Inc. | $2,500 | Grant | Cash or cash equivalent | Grants Device, General | 2021 | |
| 2021-07-08 | Edwards Lifesciences Corporation | $10,800 | Research payment | Cash or cash equivalent | Early-TAVR Trial #2016-07 | 2021 | |
| 2021-07-08 | Boston Scientific Corporation | $35 | Research payment | In-kind items and services | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | Frozen AF | 2021 |
| 2021-06-29 | Boston Scientific Corporation | $99 | Research payment | In-kind items and services | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | Frozen AF | 2021 |
| 2021-06-29 | Boston Scientific Corporation | $45 | Research payment | In-kind items and services | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | Frozen AF | 2021 |
| 2021-06-29 | Boston Scientific Corporation | $35 | Research payment | In-kind items and services | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | Frozen AF | 2021 |
| 2021-06-29 | Boston Scientific Corporation | $32 | Research payment | In-kind items and services | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | Frozen AF | 2021 |
| 2021-06-24 | Boehringer Ingelheim International GmbH | $504 | Research payment | Cash or cash equivalent | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-06-24 | Boehringer Ingelheim International GmbH | $500 | Research payment | Cash or cash equivalent | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-06-21 | Edwards Lifesciences Corporation | $3,493 | Research payment | Cash or cash equivalent | PARTNER3 2015-08 | 2021 | |
| 2021-06-07 | Edwards Lifesciences Corporation | $1,334 | Research payment | Cash or cash equivalent | Partner3 2015-08 | 2021 | |
| 2021-05-24 | Johnson & Johnson Health Care Systems Inc. | $1,000 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-05-17 | Edwards Lifesciences Corporation | $144 | Research payment | Cash or cash equivalent | PARTNER II (2010-12) | 2021 | |
| 2021-05-05 | GW Research Limited | $11,656 | Research payment | Cash or cash equivalent | GWEP1521 | 2021 | |
| 2021-04-14 | Johnson & Johnson Health Care Systems Inc. | $5,429 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-04-05 | Edwards Lifesciences Corporation | $3,126 | Research payment | Cash or cash equivalent | Early-TAVR Trial #2016-07 | 2021 | |
| 2021-04-05 | Johnson & Johnson Health Care Systems Inc. | $8 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-03-18 | Edwards Lifesciences Corporation | $14,614 | Research payment | Cash or cash equivalent | Partner3 2015-08 | 2021 | |
| 2021-03-15 | Edwards Lifesciences Corporation | $500 | Research payment | Cash or cash equivalent | Early-TAVR Trial #2016-07 | 2021 | |
| 2021-03-02 | Johnson & Johnson Health Care Systems Inc. | $25 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-03-01 | Boehringer Ingelheim International GmbH | $842 | Research payment | Cash or cash equivalent | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-02-24 | Johnson & Johnson Health Care Systems Inc. | $350 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-02-18 | Edwards Lifesciences Corporation | $218 | Research payment | Cash or cash equivalent | Partner3 2015-08 | 2021 | |
| 2021-01-29 | Johnson & Johnson Health Care Systems Inc. | $950 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-01-29 | Johnson & Johnson Health Care Systems Inc. | $329 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-01-26 | Eli Lilly and Company | $386 | Research payment | In-kind items and services | A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD | 2021 | |
| 2021-01-20 | Incyte Corporation | $5,742 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2021 | |
| 2021-01-19 | Johnson & Johnson Health Care Systems Inc. | $18 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-01-05 | Boehringer Ingelheim International GmbH | $28 | Research payment | In-kind items and services | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-01-05 | Boehringer Ingelheim International GmbH | $26 | Research payment | In-kind items and services | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-01-05 | Boehringer Ingelheim International GmbH | $22 | Research payment | In-kind items and services | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-01-05 | Boehringer Ingelheim International GmbH | $22 | Research payment | In-kind items and services | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-01-05 | Boehringer Ingelheim International GmbH | $11 | Research payment | In-kind items and services | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
| 2021-01-05 | Boehringer Ingelheim International GmbH | $11 | Research payment | In-kind items and services | JARDIANCE Drug, DIABETES | Empagliflozin and heart failure (HFpEF) | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In York, PA, county York County, PA, state Pennsylvania; placed by its city name.
| Measure | Place (city or town) York, PA | County York County, PA | State Pennsylvania |
|---|---|---|---|
| Population B01003 | 44,938 | 462,924 | 13,018,639 |
| Population, 2020 census P1 | 44,800 | 456,438 | 13,002,700 |
| Median age B01002 | 34.3 | 41.1 | 40.9 |
| Under 18 B01001 | 23.9% | 21.9% | 20.4% |
| 65 and over B01001 | 13.1% | 18.8% | 19.5% |
| Households B11001 | 17,893 | 181,583 | 5,274,853 |
| Foreign born B05002 | 11.1% | 4.1% | 7.7% |
| Median household income B19013 | $48,420 | $84,829 | $77,971 |
| Median family income B19113 | $54,727 | $102,186 | $100,262 |
| Per capita income B19301 | $26,308 | $41,601 | $44,355 |
| Poverty rate B17001 | 21.1% | 8.4% | 11.7% |
| Unemployment rate B23025 | 10.7% | 4.5% | 5.3% |
| Civilian labor force B23025 | 23,179 | 245,693 | 6,684,175 |
| Mean commute (minutes) B08013 | 23.1 | 26.3 | 26.3 |
| Bachelor's degree or higher B15003 | 17.5% | 27.6% | 35.2% |
| Housing units B25001 | 19,505 | 189,857 | 5,806,452 |
| Owner-occupied B25003 | 43.7% | 76.3% | 69.3% |
| Renters B25003 | 56.3% | 23.7% | 30.7% |
| Median home value B25077 | $119,700 | $248,600 | $254,500 |
| Median gross rent B25064 | $1,014 | $1,193 | $1,209 |
| White, not Hispanic B03002 | 33.6% | 78.9% | 73.0% |
| Black B03002 | 24.1% | 5.8% | 10.3% |
| Hispanic or Latino B03002 | 36.6% | 9.6% | 8.7% |
| Asian B03002 | 1.0% | 1.5% | 3.8% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in York, PA.
Comments